TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management

Chun Chieh Wang, Hung Yu Chang, Wei Hsian Yin, Yen Wen Wu, Pao Hsien Chu, Chih Cheng Wu, Chih Hsin Hsu, Ming Shien Wen, Wen Chol Voon, Wei Shiang Lin, Jin Long Huang, Shyh Ming Chen, Ning I. Yang, Heng Chia Chang, Kuan Cheng Chang, Shih Hsien Sung, Kou Gi Shyu, Jiunn Lee Lin, Guang Yuan Mar, Kuei Chuan ChanJen Yuan Kuo, Ji Hung Wang, Zhih Cherng Chen, Wei Kung Tseng, Wen Jin Cherng

Research output: Contribution to journalArticlepeer-review

62 Citations (Scopus)


Introduction: Heart failure (HF) is a medical condition with a rapidly increasing incidence both in Taiwan and worldwide. The objective of the TSOC-HFrEF registry was to assess epidemiology, etiology, clinical management, and outcomes in a large sample of hospitalized patients presenting with acute decompensated systolic HF. Methods: The TSOC-HFrEF registry was a prospective, multicenter, observational survey of patients presenting to 21 medical centers or teaching hospitals in Taiwan. Hospitalized patients with either acute new-onset HF or acute decompensation of chronic HFrEF were enrolled. Data including demographic characteristics, medical history, primary etiology of HF, precipitating factors for HF hospitalization, presenting symptoms and signs, diagnostic and treatment procedures, in-hospital mortality, length of stay, and dischargemedications,were collected and analyzed. Results: A total of 1509 patients were enrolled into the registry by the end of October 2014, with a mean age of 64 years (72% were male). Ischemic cardiomyopathy and dilated cardiomyopathy were diagnosed in 44% and 33% of patients, respectively. Coronary artery disease, hypertension, diabetes, and chronic renal insufficiency were the common comorbid conditions. Acute coronary syndrome, non-compliant to treatment, and concurrent infection were themajor precipitating factors for acute decompensation. The median length of hospital stay was 8 days, and the in-hospital mortality rate was 2.4%. At discharge, 62% of patients were prescribed either angiotensinconverting enzyme-inhibitors or angiotensin receptor blockers, 60% were prescribed beta-blockers, and 49% were prescribed mineralocorticoid receptor antagonists. Conclusions: The TSOC-HFrEF registry provided important insights into the current clinical characteristics and management of hospitalized decompensated systolic HF patients in Taiwan. One important observation was that adherence to guideline-directed medical therapy was suboptimal.

Original languageEnglish
Pages (from-to)400-411
Number of pages12
JournalActa Cardiologica Sinica
Issue number4
Publication statusPublished - Jul 1 2016
Externally publishedYes


  • Beta-blocker
  • Guideline
  • Heart failure
  • Renin-angiotensin system blocker
  • Taiwan
  • Treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management'. Together they form a unique fingerprint.

Cite this